Skip to Main Content

Author Details

Madeline R Luth
University of California San Diego
2017
24
11
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37995692Antiplasmodial peptaibols act through membrane directed mechanisms.Cell Chem Biol2024
36919909Human Polo-like Kinase Inhibitors as Antiplasmodials.ACS Infect Dis2023
37546892Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetase.Res Sq2023
37737220Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance.Elife2023
37197802Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38.Br J Pharmacol2023
36888694Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target.Sci Transl Med2023
34348113Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention.Cell Chem Biol2022
35653481Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.Science2022
36260689The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple <i>Plasmodium</i> kinases and life cycle stages.Sci Transl Med2022
36008486Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.Nat Commun2022
35149760Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance.Commun Biol2022
34460304The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria Parasite.Antimicrob Agents Chemother2021
33715347PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>.ACS Infect Dis2021
32286267Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway.Nat Commun2020
32078764Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials.ACS Infect Dis2020
33064992SnapShot: Antimalarial Drugs.Cell2020
31170268Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.PLoS Pathog2019
31806760Evolution of resistance in vitro reveals mechanisms of artemisinin activity in <i>Toxoplasma gondii</i>.Proc Natl Acad Sci U S A2019
31801884In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection model.Sci Transl Med2019
29451780Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery.ACS Infect Dis2018
30523084Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.Science2018
30373366Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome.J Med Chem2018
27889151Efficacy of post-harvest rinsing and bleach disinfection of E. coli O157:H7 on spinach leaf surfaces.Food Microbiol2017
29284029CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).PLoS Negl Trop Dis2017
  • 1 - 24 of 24

Recommended Authors

University of California berkeley
Career Start Year 2013
Number of shared co-authors 4
Vagelos College of Physicians and Surgeons, Columbia University
Career Start Year 2008
Number of shared co-authors 0
CSIR - National Chemical Laboratory
Career Start Year 2008
Number of shared co-authors 1
Johns Hopkins School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Florida International University
Career Start Year 2005
Number of shared co-authors 0
Global Health Pharma Unit
Career Start Year 2005
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 1
University of Nebraska at Omaha
Career Start Year 2003
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 4
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 2
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1997
Number of shared co-authors 1
King Abdullah University of Science and Technology
Career Start Year 1997
Number of shared co-authors 1
Nanyang Technological University
Career Start Year 1996
Number of shared co-authors 1
RWTH Aachen University
Career Start Year 1995
Number of shared co-authors 0
University of Illinois at Urbana-Champaign
Career Start Year 1995
Number of shared co-authors 0
Institut fur Biochemie und Molekularbiologie, Universitat Freiburg
Career Start Year 1994
Number of shared co-authors 2
Center for Genomics and Systems Biology
Career Start Year 1993
Number of shared co-authors 3
University of Toronto
Career Start Year 1991
Number of shared co-authors 3
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1987
Number of shared co-authors 7
University of Washington
Career Start Year 1986
Number of shared co-authors 1
University of Washington
Career Start Year 1984
Number of shared co-authors 1
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Career Start Year 1982
Number of shared co-authors 6
Boler-Parseghian Center for Rare and Neglected Disease, University of Notre Dame
Career Start Year 1982
Number of shared co-authors 0
University of California at San Francisco
Career Start Year 1979
Number of shared co-authors 6
Seattle Children's Research Institute, University of Washington
Career Start Year 1977
Number of shared co-authors 0
University of Dundee
Career Start Year 1974
Number of shared co-authors 5
Harvard Medical School, Blavatnik Institute
Career Start Year 1973
Number of shared co-authors 5
Center for Molecular Parasitology, Drexel University College of Medicine
Career Start Year 1971
Number of shared co-authors 3

Collaborators

University of California San Diego
Co-authored papers 21
University of California San Diego
Co-authored papers 14
The Broad Institute
Co-authored papers 6
Harvard T.H. Chan School of Public Health
Co-authored papers 6
University of California
Co-authored papers 5
a division of The Scripps Research Institute La Jolla
Co-authored papers 3
Columbia University Irving Medical Center
Co-authored papers 3
University of California
Co-authored papers 3
University of California
Co-authored papers 2
University of California
Co-authored papers 2
University of California san francisco
Co-authored papers 2
The George Washington University School of Medicine and Health Sciences
Co-authored papers 2
Chang Gung Memorial Hospital
Co-authored papers 2
University of Toronto
Co-authored papers 1
University of Toronto
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
University of California
Co-authored papers 1
Scripps Institution of Oceanography, University of California San Diego
Co-authored papers 1
University of Toronto
Co-authored papers 1
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne
Co-authored papers 1
Nagoya City University
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
University of California
Co-authored papers 1
University of California
Co-authored papers 1
Genomics Institute of the Novartis Research Foundation
Co-authored papers 1
University of California
Co-authored papers 1
University of California
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Botnar Research Centre, University of Oxford
Co-authored papers 1